In a previous issue of Critical Care, Wells and colleagues [1] report on their retrospective cohort study examining the relationship between serum sodium and intracranial pressure (ICP) with severe traumatic brain injury (TBI). Th is is an ongoing topic of interest to neuro intensivists as hyperosmolar therapy remains a treatment option for elevated ICP [2] . We commend the authors for their contribution to a fundamentally important issue in neurocritical care; however, several issues deserve further discussion.
Abstract
The observational literature suggests that hypernatremia is associated with worse outcomes in patients with traumatic brain injury. In a previous issue of Critical Care, Wells and colleagues add to this literature by failing to show an association between hypernatremia and reduced intracranial pressure. However, we must bear in mind many limitations of observational methods before eliminating hyperosmolar therapy from our armamentarium. We thank Griesdale and colleagues for their thoughtful letter describing concerns with our study, specifi cally the retrospective design and statistical tests. Owing to the lack of literature supporting the benefi ts of HTS to induce hypernatremia in patients with TBI, we pragmatically evaluated this practice in one of the largest studies to date [1, 5, 6] . We agree with the limitations mentioned by Griesdale and colleagues in regard to the lack of a formalized TBI protocol and the inclusion of various doses of HTS, and we addressed this in our discussion. Importantly, patients in our study were treated with the same general approach to hyperosmolar therapy (84% of patients received 3% NaCl boluses) [1] .
In regard to adjustment for baseline characteristics, we performed linear regression in important subgroups divided by baseline ICP and Glasgow Coma Scale score.
